Procedure Volume Patient Data Patient Conditions Reviews General Payments Back to Top

Home > VA Providers > Urologists

Dr. R. Byron Osborne, MD

(Dr. Robert Byron Osborne, MD)

(No ratings)

Specializes in: Urology (Urinary Tract Disease)

Virginia Commonwealth University (VCU) School of Medicine (1985)

Professional interests include: benign prostatic hyperplasia (enlarged prostate), bladder cancer, prostate cancer, and more.

155 Riverbend Drive Suite A
Charlottesville, VA 22911

(434) 295-0184

Dr. R. Byron Osborne, MD is an urologist in Charlottesville, VA specializing in urology (urinary tract disease). He graduated from Virginia Commonwealth University (VCU) School of Medicine in 1985 and has 40 years of experience. Dr. R. Byron Osborne, MD is affiliated with Sentara Health, UROLOGICAL ASSOCIATES, LTD and PIEDMONT STONE CENTER PLLC.

Office Locations

Address:

155 Riverbend Drive Suite A
Charlottesville, VA 22911

Some issues Dr. R. Byron Osborne, MD can help you with:

Benign Prostatic Hyperplasia (Enlarged Prostate)

Benign prostatic hyperplasia (BPH) is a noncancerous condition in which the prostate gland becomes enlarged. BPH affects about half of men between the ages of 50 and 60, and approximately 80% of men over 80. As the prostate grows in size, it can press down on the tube where urine flows out of the body (the urethra) and cause urinary problems.

Medication can relieve mild to moderate symptoms of BPH, such as frequent urination, incomplete bladder emptying, a weak urine stream, and straining while urinating. However, other forms of treatment may be more appropriate if an individual has pain with urination, frequent urinary tract infections, or is unable to urinate. The size of the prostate and the severity of their symptoms will determine the type of treatment they need. If the prostate is not very large, doctors will likely recommend a transurethral procedure. This minimally invasive technique involves the insertion of a scope into the urethra. The most common transurethral procedures for BPH are:

Transurethral incision of the prostate or TUIP, where the surgeon uses the scope to make small cuts in the area of the prostate that meets the bladder. These cuts will open up the pathway for urine and allow it to flow with more ease.
Transurethral needle ablation or TUNA, where needles are inserted through the scope and into the prostate. The needles use radiofrequency waves to destroy excess prostate tissue.
Laser prostate ablation, where lasers pass through the scope to melt away the part of the prostate causing urine blockage.
Transurethral resection of the prostate or TURP, where the inside of the prostate is trimmed and removed one tiny piece at a time using the scope.

If the prostate is too big for a transurethral procedure, an individual may need a simple prostatectomy, which can be done in one of three ways: laparoscopic, robotic, or open. During a laparoscopic simple prostatectomy, a surgeon makes several small incisions on the belly. Then they insert a long tube with a camera into one of the cuts and surgical instruments into the others. Using the camera to see inside the belly, they carefully removes the enlarged part of the prostate. Robotic simple prostatectomy uses the same techniques as the laparoscopic method, but the surgery is done with the help of a robot. For men with very large prostates, open simple prostatectomy may be the best treatment option. This surgery differs from the other approaches in that it requires a much larger incision.

Most transurethral treatments for BPH, like TUIP, TUNA, and laser prostate ablation, are done in the doctor's office or outpatient surgery center. TURP and simple prostatectomy, however, need to be performed in the hospital and require an average stay of one to three days. Patients should wait a week before doing any strenuous activities after a TUIP, TUNA, or laser prostate ablation, and about four to six weeks after a TURP or simple prostatectomy. Although these treatments improve BPH symptoms for most patients, it is important to be aware of the risks involved, such as urine control issues, tightening of the urethra, and erectile dysfunction.

Kidney Stones

Kidney stones are hard deposits that form in the kidneys, made up of minerals that are normally present in urine. They can vary in size, from as small as a grain of sand to as large as a nickel, occasionally even larger. Sometimes they lodge in the kidney, and sometimes they break free and make their way out through the urinary tract, which can be extremely painful.

Kidney stones can be smooth or jagged and are yellow to brown in color. They are mostly comprised of the minerals calcium, oxalate, and phosphorus. Examining the stones to see what they are made of can show what caused the stone to be formed in the first place. For example, a stone made of mostly calcium, which is the most common type, can happen any time the urine becomes too concentrated due to dehydration or a blockage in the kidney. A uric acid stone forms when acid levels in the urine get too high, usually due to excessive consumption of animal protein such as meat and fish. A struvite stone is a sign of certain infections, and a cystine stone can be due to a genetic disorder that raises the risk of kidney stones.

The most common symptom of kidney stones is pain, either in the back or lower abdomen, or severe pain when urinating. There may also be blood in the urine. Treatment for kidney stones depends on how large the stone is. Very small stones can pass out of the body on their own, and they do not require treatment other than drinking adequate water and taking pain killers. Larger stones need to be broken apart and removed. The main treatment options are:

Shock wave lithotripsy, which uses sound wave vibrations to break apart the stone
Percutaneous nephrolithotomy, or the use of a very tiny tool (like a wire inserted through the back) to break apart and remove the stone
Ureteroscopy, a thin tube inserted through the urethra and bladder to the stone, where tiny tools can grasp the stone and remove

People who have had one kidney stone are at risk of developing another. To reduce this risk, patients are given instructions specific to the type of stone they developed. Generally the instructions will include drinking more water to dilute the urine, but it may also involve lowering sodium intake or eating less meat.

blood draw	665
catheterization	41
diagnostic procedures	26
doctor visit	1481
hormone therapy	115
lab tests	2119
minimally invasive procedures	115
minor procedures	27
urologic procedures	470

**Gender**
Male	580
Female	170

**Ethnicity**
Non-Hispanic White	676
Black	52
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	316
From 75 to 84	282
85 and over	129
Less than 65	23

Hypertension	64
High Cholesterol	58
Stroke	4
Ischemic Heart Disease	31
Depression	14
Chronic Kidney Disease	21
Asthma	5
Osteoperosis	5
Atrial Fibrilation	15
Heart Failure	13
Chronic Obstructive Pulmonary Disease	8
Diabetes	31
Dementia	9
Cancer	21

biological response modifier (BRM) therapy	58
blood draw	720
catheterization	53
chemotherapy	58
diagnostic procedures	37
doctor visit	1542
hormone therapy	124
lab tests	2250
minimally invasive procedures	157
minor procedures	38
urologic procedures	593

**Gender**
Male	569
Female	165

**Ethnicity**
Non-Hispanic White	658
Black	56
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	307
From 75 to 84	281
85 and over	126
Less than 65	20

Hypertension	63
High Cholesterol	59
Stroke	4
Ischemic Heart Disease	32
Depression	15
Chronic Kidney Disease	25
Asthma	7
Osteoperosis	3
Atrial Fibrilation	15
Heart Failure	12
Chronic Obstructive Pulmonary Disease	8
Diabetes	29
Dementia	9
Cancer	21

biological response modifier (BRM) therapy	72
blood draw	710
catheterization	76
chemotherapy	72
diagnostic procedures	27
doctor visit	1496
hormone therapy	100
lab tests	2162
minimally invasive procedures	153
minor procedures	28
potassium test	29
urologic procedures	759

**Gender**
Male	1126
Female	294

**Ethnicity**
Non-Hispanic White	1264
Black	112
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	586
From 75 to 84	580
85 and over	218
Less than 65	36

Hypertension	64
High Cholesterol	57
Stroke	5
Ischemic Heart Disease	31
Depression	14
Chronic Kidney Disease	27
Asthma	8
Osteoperosis	3
Atrial Fibrilation	13
Heart Failure	14
Chronic Obstructive Pulmonary Disease	9
Diabetes	29
Dementia	10
Cancer	22

biological response modifier (BRM) therapy	72
blood draw	769
catheterization	81
chemotherapy	72
diagnostic procedures	33
doctor visit	1503
hormone therapy	126
lab tests	2221
lithotripsy (stone fragmentation)	13
minimally invasive procedures	132
minor procedures	34
potassium test	27
urologic procedures	767

**Gender**
Male	629
Female	141

**Ethnicity**
Non-Hispanic White	690
Black	58
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	346
From 75 to 84	298
85 and over	108
Less than 65	18

Hypertension	62
High Cholesterol	52
Stroke	3
Ischemic Heart Disease	29
Depression	14
Chronic Kidney Disease	27
Asthma	11
Osteoperosis	3
Atrial Fibrilation	12
Heart Failure	12
Chronic Obstructive Pulmonary Disease	10
Diabetes	29
Dementia	9
Cancer	22

biological response modifier (BRM) therapy	72
blood draw	796
catheterization	72
chemotherapy	72
diagnostic procedures	19
doctor visit	1640
hormone therapy	161
lab tests	2415
minimally invasive procedures	121
minor procedures	20
potassium test	16
urologic procedures	925

**Gender**
Male	655
Female	162

**Ethnicity**
Non-Hispanic White	737
Black	56
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	361
From 75 to 84	314
85 and over	121
Less than 65	21

Hypertension	61
High Cholesterol	43
Stroke	3
Ischemic Heart Disease	30
Depression	14
Chronic Kidney Disease	28
Asthma	5
Osteoperosis	3
Atrial Fibrilation	11
Heart Failure	12
Chronic Obstructive Pulmonary Disease	9
Diabetes	29
Dementia	10
Cancer	23

biological response modifier (BRM) therapy	49
blood draw	761
catheterization	78
chemotherapy	49
diagnostic procedures	24
doctor visit	1635
hormone therapy	139
lab tests	2431
minimally invasive procedures	137
minor procedures	25
potassium test	20
urologic procedures	1069

**Gender**
Male	617
Female	159

**Ethnicity**
Non-Hispanic White	695
Black	58
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	325
From 75 to 84	308
85 and over	126
Less than 65	17

Hypertension	61
High Cholesterol	55
Stroke	3
Ischemic Heart Disease	30
Depression	12
Chronic Kidney Disease	28
Asthma	5
Osteoperosis	4
Atrial Fibrilation	13
Heart Failure	12
Chronic Obstructive Pulmonary Disease	9
Diabetes	28
Dementia	9
Cancer	24

biological response modifier (BRM) therapy	45
blood draw	739
catheterization	56
chemotherapy	45
diagnostic procedures	25
doctor visit	1644
hormone therapy	112
hospital care	16
inpatient care	16
lab tests	2407
lithotripsy (stone fragmentation)	12
minimally invasive procedures	124
minor procedures	26
potassium test	25
urologic procedures	919

**Gender**
Male	661
Female	161

**Ethnicity**
Non-Hispanic White	735
Black	57
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	367
From 75 to 84	297
85 and over	143
Less than 65	15

Hypertension	60
High Cholesterol	55
Stroke	4
Ischemic Heart Disease	31
Depression	16
Chronic Kidney Disease	29
Asthma	5
Osteoperosis	4
Atrial Fibrilation	13
Heart Failure	13
Chronic Obstructive Pulmonary Disease	9
Diabetes	27
Dementia	10
Cancer	25

blood draw	698
catheterization	26
diagnostic procedures	19
doctor visit	1580
hormone therapy	105
lab tests	2300
lithotripsy (stone fragmentation)	18
minimally invasive procedures	142
minor procedures	20
potassium test	19
urologic procedures	1060

**Gender**
Male	701
Female	186

**Ethnicity**
Non-Hispanic White	781
Black	66
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	391
From 75 to 84	343
85 and over	134
Less than 65	19

Hypertension	58
High Cholesterol	52
Stroke	4
Ischemic Heart Disease	32
Depression	15
Chronic Kidney Disease	31
Asthma	5
Osteoperosis	4
Atrial Fibrilation	13
Heart Failure	13
Chronic Obstructive Pulmonary Disease	8
Diabetes	27
Dementia	8
Cancer	23

Average Medicare Procedure Volume From 2013 - 2021

Volume of procedures performed by Dr. R. Byron Osborne, MD for Medicare patients.

The highest averages for the top procedures that Dr. R. Byron Osborne, MD treated as an urologist in Charlottesville, VA were lab tests, urologic procedures, blood draw and chronic care.

anorectal procedures	31
biological response modifier (BRM) therapy	69
blood draw	814
catheterization	68
chemotherapy	69
chronic care	269
diagnostic procedures	31
doctor visit	1857
hormone therapy	134
hospital care	24
inpatient care	24
lab tests	2621
lithotripsy (stone fragmentation)	21
minimally invasive procedures	162
minor procedures	28
pelvic imaging	69
potassium test	21
ultrasound (sonogram)	69
urologic procedures	981

Average Medicare Patient Data From 2013 - 2021

Information about Medicare patients treated by Dr. R. Byron Osborne, MD.

**Gender**
Female	143
Male	553

**Ethnicity**
Black / African American	51
Asian / Pacific Islander	0
Non-Hispanic White	623
Native American / Alaskan Native	0
Hispanic	0
Other	0

**Age**
85 and over	110
75 to 84	270
Less than 65	16
65 to 74	299

Average of Total of Conditions of Medicare patients treated by Dr. R. Byron Osborne, MD From 2013 - 2021

The highest averages of the most common conditions of Medicare patients that Dr. R. Byron Osborne, MD treated were hypertension, high cholesterol, ischemic heart disease and diabetes.

Hypertension	49
High Cholesterol	43
Stroke	3
Ischemic Heart Disease	24
Depression	11
Chronic Kidney Disease	21
Asthma	5
Osteoporosis	2
Heart Failure	10
Chronic Obstructive Pulmonary Disease	7
Diabetes	22
Atrial Fibrillation	10
Dementia	7
Cancer	18

Education & Training

Dr. R. Byron Osborne, MD graduated from Virginia Commonwealth University (VCU) School of Medicine in 1985. He completed residency at Virginia Commonwealth University (VCU) Affiliated Hospitals. He has a state license in Virginia.

Medical School: Virginia Commonwealth University (VCU) School of Medicine (1985)

Residency: Virginia Commonwealth University (VCU) Affiliated Hospitals (1987)

Licensed In: Virginia

Affiliations & Hospitals

Dr. R. Byron Osborne, MD is associated with these hospitals and organizations:

Sentara Health

UROLOGICAL ASSOCIATES, LTD

PIEDMONT STONE CENTER PLLC

Ratings & Reviews

Dr. R. Byron Osborne, MD does not have any reviews yet, be the first to leave a review of Dr. R. Byron Osborne, MD here: Leave a Review

(No ratings)

Leave a Review

General Payments

These charts describe general payments received by Dr. R. Byron Osborne, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.

**Payments by Company**
Physician Discoveries, LLC	$8,338 $8,338
Astellas Pharma US Inc	$2,290 XTANDI $851	Myrbetriq $554	Vesicare $503	TARCEVA $24	Veozah $16	Other $344
Pfizer Inc.	$1,340 XTANDI $490	ORGOVYX $399	TOVIAZ $153	PAXLOVID $128	VIAGRA $128	Other $41
Janssen Biotech, Inc.	$1,015 Erleada $926	ZYTIGA $89
AbbVie, Inc.	$962 Androgel $600	Lupron $182	Lupron Depot $126	$52
Other	$6,287 Lupron Depot $482	PROVENGE $474	ORGOVYX $429	GEMTESA $382	Nubeqa $227	Other $4,294

**Types of Payments**
Food and Beverage	$11,328
Current or prospective ownership or investment interest	$8,338
Education	$566

Ownership and Interest Payments

This table describes ownership payments received by Dr. R. Byron Osborne, MD.

Physician Discoveries, LLC	2015	$7,495.97	Physician Covered Recipient	limited liability company membership in Physician Discovery Holdings, LLC
Physician Discoveries, LLC	2013	$6,902.58	Physician Covered Recipient	limited liability company membership in Physician Discovery Holdings, LLC
Physician Discoveries, LLC	2016	$5,920.06	Physician Covered Recipient	limited liability company membership in Physician Discovery Holdings, LLC
Physician Discoveries, LLC	2014	$4,772.42	Physician Covered Recipient	limited liability company membership in Physician Discovery Holdings, LLC
Physician Discoveries, LLC	2017	$3,530.34	Physician Covered Recipient	limited liability company membership in Physician Discovery Holdings, LLC

Biography

Dr. Robert Osborne practices urology (urinary tract disease). Areas of expertise for Dr. Osborne include bladder cancer, erectile dysfunction (impotence), and benign prostatic hyperplasia (enlarged prostate). Dr. Osborne is professionally affiliated with Sentara Health. After attending Virginia Commonwealth University (VCU) School of Medicine, he completed his residency training at a hospital affiliated with Virginia Commonwealth University (VCU).